Sorrento Therapeutics, Inc. (SRNE): Price and Financial Metrics
Sorrento Therapeutics, Inc. (SRNE)
Today's Latest Price: $8.22 USD
0.67 (-7.54%)
Updated Oct 20 4:00pm
Add SRNE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SRNE Stock Summary
- With a price/sales ratio of 60.54, Sorrento Therapeutics Inc has a higher such ratio than 96.32% of stocks in our set.
- With a year-over-year growth in debt of -28.83%, Sorrento Therapeutics Inc's debt growth rate surpasses merely 9.96% of about US stocks.
- In terms of volatility of its share price, SRNE is more volatile than 96.07% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Sorrento Therapeutics Inc are VERU, RTRX, KPTI, VECO, and ATNX.
- SRNE's SEC filings can be seen here. And to visit Sorrento Therapeutics Inc's official web site, go to www.sorrentotherapeutics.com.
SRNE Stock Price Chart Interactive Chart >
SRNE Price/Volume Stats
| Current price | $8.22 | 52-week high | $19.39 |
| Prev. close | $8.89 | 52-week low | $1.45 |
| Day low | $8.10 | Volume | 17,912,700 |
| Day high | $8.92 | Avg. volume | 26,863,979 |
| 50-day MA | $9.63 | Dividend yield | N/A |
| 200-day MA | $5.71 | Market Cap | 2.15B |
Sorrento Therapeutics, Inc. (SRNE) Company Bio
Sorrento Therapeutics is a clinical stage oncology company developing new treatments for cancer and associated pain. The company was founded in 2006 and is based in San Diego, California.
Loading social stream, please wait...